Navigation Links
Facing up to the ‘complete face transplant’ isse

The Royal Free Hospital in Northwest London where Peter Butler and his team work is buzzing with anticipation, as they await the approval// from the ethics board for going ahead with the ‘full face’ transplant surgery.

Last December, the ethics board had given Butler and his team permission to find a suitable patient for the surgery. After educating patients regarding the risks involved, now it is in the final stage of receiving approval to carry out the process.

To quote Butler,” We applied to the ethical commission to use the selection tools we have on people seeking facial transplantation and that was approved in December. The next part was to educate the patient of the risks, and that leads you on to the consent process, approved three or four weeks ago. And the final stage is to get ethical approval to do the procedure. Obviously there is a big question mark about Wednesday, but my feeling is the hospital would be unlikely to start the process if we can’t finish it.”
'"/>




Page: 1

Related medicine news :

1. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
2. Hospitals Facing Huge Losses From Healthy Patients Yet To Discharge
3. Uganda Facing Huge Problem Due to Combination of HIV And TB
4. Patients Undergoing Breast Radiation Are Facing Complications
5. Marathon Boy Budhia Singh Facing Cash Crunch
6. Asia- Facing a Health Doom After a Wealth Boom
7. Junior Doctors Facing More Misery Because of Contract Deadlock: BMA

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Facing the face transplant isse

(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allreci...ord-high Thanksgiving traffic numbers, with more t...ng, providing a clear picture of what was served o...e Thanksgiving meal in 2009 weighed in at 2,225 ca... year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...an,orthopedic implants company focused on silicon ... Ashok Khandkar, Ph.D., Chief Executive,Officer, a...f Financial,Officer, are scheduled to present at t...Khandkar and Mr. Gallacher will provide a general ...
...A preparation with no,detectable large RNA and fur... developing area of RNAi, ST....s pleased to introduce mirPremier(TM) microRNA Iso...,purifying and enriching miRNA along with other sm...
...ed those with Lou Gehrig,s disease , , THU...ntibiotic minocycline against amyotrophic lateral ...ed because patients taking the drug had a signific...s such as multiple sclerosis, said a report publis...
...aloon will,host a tribute to the late songwriter W...PM to raise research money and awareness for Mesot...much loved and respected troubadour.,Tickets for t...ds from the show will go to The Mesothelioma Appli...
...anxiety from stressful life situations may be more...ast the first six months after the event, accordin...the journal SLEEP. , The study, authored by Jussi...urbed sleep and 2,572 with disturbed sleep, all of...
...,unveil the successor to its unique Xcelodose syst...and vials at the American Association of,Pharmaceu...o (November 11th,-15th, 2007). The new Xcelodose ...nded software functionality. These enhancements w...
Other Medicine News:Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 2Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 3Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma 2Health News:Anxiety linked to sleep disturbances 2Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3
...es,Pharmaceuticals, Inc., (Nasdaq: ALSE ), announ...n the initial stage of the ALTROPANE(R) Parkinson,...cal trial program. This,subject was enrolled at th...er the direction of Principal Investigator Dr. Ray...ment of Neurology., ALTROPANE is a diagnostic mol...
...(TM) shows lifesaving potential -, - HGS on trac...ockpile beginning in 2008...s, Inc. (Nasdaq: HGSI ) today announced that the ...e-saving potential of its human,monoclonal antibod... that a,single dose of ABthrax, administered witho...
Other Medicine Technology:Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 7
Lasik Irrigator - 4 ports
Lasik Cannula - Rosen
Anterior Chamber Maintainer
Sub-Tenon's Cannula
Medicine Products: